Trial NCT04492722

View at ClinicalTrials.gov 
Org. Study IDs: D7551C00001
Secondary IDs: 2020-002263-54

Last trial update was posted on 2023-12-26

MeSH Interventions

Dapagliflozin

MeSH Conditions

Kidney Diseases Renal Insufficiency, Chronic

Other Conditions

Chronic Kidney Disease

Stopping Reasons

The Sponsor decided to terminate the study early due to lack of efficacy. There were no safety concerns related to the study.

Limitations And Caveats

Following study termination and reduced scope of the analysis, the PK analysis has not been performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID